Annual Meeting & Research Update
January 23, 2016
Pomona, CA --
The National Multiple Sclerosis Society, Southern California & Nevada Chapter held its Annual Meeting of Members at the Sheraton Fairplex in Pomona, CA. Chapter President Julie Kaufer, Board Chair Kim Phillips, and Finance Chair-Elect Larry McEwen updated the members on the Chapter's 2015 fundraising activities and program and services delivery.
Following the remarks, Dr. Daniel Pelletier, Vice-Chair of Research and Chief of the Neuro-Immunology and MS Division of the Keck School of Medicine of USC, described his research on single gene analysis and its influence in diagnosing MS earlier. He also updated members on new initatives at the USC MS Comprehensive Care Center to expand clinical services and standardize assessments.
Click below to read more about Dr. Pelletier and the latest in research at USC:
About the Southern California & Nevada Chapter of the National Multiple Sclerosis (MS) Society
The Southern California & Nevada Chapter of the National MS Society provides comprehensive programs and advocacy to assist and empower the more than 20,000 individuals residing in Southern and Central California and Nevada who are affected by MS annually. The Southern California & Nevada Chapter is also a driving force of research for the prevention, treatment and cure of MS and contributes funds to support 350 National MS Society research projects worldwide. The Chapter has offices in Bakersfield, Fresno, Las Vegas, Los Angeles, Ontario, Reno and Santa Barbara.
About Multiple Sclerosis
Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.